2-(3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Acetic Acid 2-(3-(4-溴-2-氟苄基)-4-氧代-3,4-二氢酞嗪-1-基)乙酸
CAS 72702-95-5 MFCD00204117
化学结构图
SMILES: OC(=O)CC1=NN(CC2=CC=C(Br)C=C2F)C(=O)C2C=CC=CC1=2
化学属性
| Mol. Formula | C17H12BrFN2O3 |
|---|---|
| Mol. Weight | 391.195 |
别名和识别编码
| Chemical Name | 2-(3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Acetic Acid |
|---|---|
| Chemical Name Translation | 2-(3-(4-溴-2-氟苄基)-4-氧代-3,4-二氢酞嗪-1-基)乙酸 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Bresson E, et al. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab. 2011 Jan;96(1):210-9.
- [3]. Calcutt NA, et al. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia. 2004 Apr;47(4):718-24.
- [1]. Ward WH, et al. Ponalrestat: a potent and specific inhibitor of aldose reductase. Biochem Pharmacol. 1990 Jan 15;39(2):337-46.
- [1]. Ward WH, et al. Ponalrestat: a potent and specific inhibitor of aldose reductase. Biochem Pharmacol. 1990 Jan 15;39(2):337-46.
- [2]. Bresson E, et al. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab. 2011 Jan;96(1):210-9.
- [3]. Calcutt NA, et al. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment wi
